|
|
Volumn 20, Issue 2, 2008, Pages 198-202
|
|
Refractory gout: What is it and what to do about it?
|
|
Author keywords
Febuxostat; Gout; Inflammasome; Pegloticase; Uric acid; Uricase
|
|
Indexed keywords
ALLANTOIN;
ALLOPURINOL;
ANTIINFLAMMATORY AGENT;
CD14 ANTIGEN;
COLCHICINE;
CORTICOSTEROID;
DICLOFENAC;
ETANERCEPT;
FEBUXOSTAT;
INFLIXIMAB;
INTERLEUKIN 1;
INTERLEUKIN 6;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXIPURINOL;
PEGLOTICASE;
PLACEBO;
RASBURICASE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
TOLL LIKE RECEPTOR 2;
TOLL LIKE RECEPTOR 4;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
URATE;
URICOZYME;
CATALYSIS;
CHRONIC KIDNEY DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
DIZZINESS;
DRUG HALF LIFE;
DRUG WITHDRAWAL;
FUNCTIONAL DISEASE;
GOUT;
GOUT FLARE;
HUMAN;
JOINT DESTRUCTION;
MYALGIA;
NAUSEA;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RESPIRATORY TRACT DISEASE;
REVIEW;
SINGLE DRUG DOSE;
TREATMENT DURATION;
URIC ACID BLOOD LEVEL;
URIC ACID NEPHROPATHY;
VOMITING;
ALLOPURINOL;
ANTI-INFLAMMATORY AGENTS;
GOUT;
HUMANS;
INFLAMMATION;
TREATMENT FAILURE;
URATE OXIDASE;
URICOSURIC AGENTS;
|
|
EID: 40349112725
PISSN: 10408711
EISSN: None
Source Type: Journal
DOI: 10.1097/BOR.0b013e3282f4eff5 Document Type: Review |
|
Times cited : (72)
|
|
References (45)
|
